{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:19:42Z","timestamp":1783545582010,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.xphs.2024.04.028","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T16:16:55Z","timestamp":1714407415000},"page":"2093-2100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics and Preclinical Safety Studies of Modified Endolysin-based Gel for Topical Application"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7025-8056","authenticated-orcid":false,"given":"Nataliia P.","family":"Antonova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1965-0700","authenticated-orcid":false,"given":"Daria V.","family":"Vasina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor V.","family":"Grigoriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5197-2465","authenticated-orcid":false,"given":"Evgeny V.","family":"Usachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Aleshkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4724-2464","authenticated-orcid":false,"given":"Aleksei M.","family":"Vorobev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5050-2274","authenticated-orcid":false,"given":"Aleksei I.","family":"Laishevtsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Kapustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliy A.","family":"Savinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia N.","family":"Anurova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia A.","family":"Zackharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timofey A.","family":"Remizov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine V.","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey M.","family":"Yudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2024.04.028_bib0004","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1080\/1040841X.2020.1809346","article-title":"Advanced engineering of third-generation lysins and formulation strategies for clinical applications","volume":"46","author":"De Maesschalck","year":"2020","journal-title":"Crit Rev Microbiol"},{"issue":"4","key":"10.1016\/j.xphs.2024.04.028_bib0007","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/AAC.02232-13","article-title":"Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient","volume":"58","author":"Jun","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.xphs.2024.04.028_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02629-16","article-title":"Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers","volume":"61","author":"Jun","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2024.04.028_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.748718","article-title":"Discovering the potentials of four phage endolysins to combat gram-negative infections","volume":"12","author":"Vasina","year":"2021","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.xphs.2024.04.028_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000473872","article-title":"Successful treatment of chronic staphylococcus aureus-related dermatoses with the topical endolysin Staphefekt SA.100: a report of 3 cases","volume":"9","author":"Tott\u00e9","year":"2017","journal-title":"Case Rep Dermatol"},{"issue":"3","key":"10.1016\/j.xphs.2024.04.028_bib0001","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/v11030284","article-title":"Broad bactericidal activity of the Myoviridae bacteriophage lysins LysAm24, LysECD7, and LysSi3 against gram-negative ESCAPE pathogens","volume":"11","author":"Antonova","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.xphs.2024.04.028_bib0002","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/biom10030440","article-title":"Modulation of Endolysin LysECD7 Bactericidal Activity by Different Peptide Tag Fusion","volume":"10","author":"Antonova","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.xphs.2024.04.028_bib0015","unstructured":"Patent RU2781050C1, 28.09.2021. Bactericidal pharmaceutical composition for topical application in the form of an endolysin-containing bactericidal gel."},{"issue":"S1","key":"10.1016\/j.xphs.2024.04.028_bib0003","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1134\/S0003683822100027","article-title":"Engineered endolysin LysECD7-SMAP reveals antimicrobial synergy with antibiotics and restores sensitivity in gram-negative pathogens","volume":"58","author":"Arshinov","year":"2022","journal-title":"Appl Biochem Microbiol"},{"issue":"10","key":"10.1016\/j.xphs.2024.04.028_bib0008","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/1440-1681.12613","article-title":"Pharmacokinetics of the phage endolysin-based candidate drug SAL200 in monkeys and its appropriate intravenous dosing period","volume":"43","author":"Jun","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"12","key":"10.1016\/j.xphs.2024.04.028_bib0012","doi-asserted-by":"crossref","first-page":"e00311","DOI":"10.1128\/AAC.00311-20","article-title":"A choline-recognizing monomeric lysin, ClyJ-3m, shows elevated activity against Streptococcus pneumoniae","volume":"64","author":"Luo","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.xphs.2024.04.028_bib0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/v10110638","article-title":"Safety studies of pneumococcal endolysins Cpl-1 and Pal","volume":"10","author":"Harhala","year":"2018","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.xphs.2024.04.028_bib0016","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/19420862.2015.1115937","article-title":"Key factors influencing ADME properties of therapeutic proteins","volume":"8","author":"Tibbitts","year":"2016","journal-title":"MAbs"},{"issue":"9","key":"10.1016\/j.xphs.2024.04.028_bib0009","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.drudis.2019.06.002","article-title":"Skin metabolism phase I and phase II enzymes in native and reconstructed human skin: a short review","volume":"24","author":"Kazem","year":"2019","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.xphs.2024.04.028_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2017.12.009","article-title":"Skin wound healing in humans and mice: challenges in translational research","volume":"90","author":"Zomer","year":"2018","journal-title":"J Dermatol Sci"},{"issue":"8","key":"10.1016\/j.xphs.2024.04.028_bib0013","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00204-018-2232-x","article-title":"Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models","volume":"92","author":"Oesch","year":"2018","journal-title":"Arch Toxicol"},{"issue":"7","key":"10.1016\/j.xphs.2024.04.028_bib0011","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138920009789895499","article-title":"Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies","volume":"10","author":"Lin","year":"2009","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.xphs.2024.04.028_bib0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41232-017-0042-9","article-title":"Regulation of blood vascular permeability in the skin","volume":"37","author":"Ono","year":"2017","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.xphs.2024.04.028_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ddtec.2016.09.006","article-title":"Pharmacological considerations for predicting PK\/PD at the site of action for therapeutic proteins","volume":"22","author":"Wang","year":"2016","journal-title":"Drug Discov Today Technol"},{"issue":"2","key":"10.1016\/j.xphs.2024.04.028_bib0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00441-012-1355-2","article-title":"Protease-armed bacteria in the skin","volume":"351","author":"Koziel","year":"2013","journal-title":"Cell Tissue Res"},{"issue":"10","key":"10.1016\/j.xphs.2024.04.028_bib0019","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/antibiotics10101260","article-title":"Efficacy of the endolysin-based antibacterial gel for treatment of anaerobic infection caused by fusobacterium necrophorum","volume":"10","author":"Vasina","year":"2021","journal-title":"Antibiotics"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924001564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354924001564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:49:50Z","timestamp":1724741390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354924001564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0022354924001564"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2024.04.028","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and Preclinical Safety Studies of Modified Endolysin-based Gel for Topical Application","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2024.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}